†These authors contributed equally.
Academic Editor: Maurizio Pieroni
Background: The classic electrocardiogram (ECG) criteria have been
applied to left ventricular hypertrophy (LVH) screening but have low sensitivity.
Recently, the newly proposed Peguero-Lo Presti criterion has been proven to be
more sensitive in detecting LVH in patients with hypertension than several
current ECG criteria. The diagnostic value of the Peguero-Lo Presti criterion in
hypertrophic cardiomyopathy (HCM) patients has not been fully evaluated. This
study aims to test whether the new Peguero-Lo Presti criterion can improve the
diagnostic performance in patients with HCM. Methods: This study
included HCM patients and sex-and age-matched healthy control subjects. The
diagnostic performance of the Peguero-Lo Presti criterion was evaluated along
with the Sokolow-Lyon criterion, Cornell criterion, and total 12-lead voltage
criterion. Results: Overall, 63 HCM patients and 63 controls were
enrolled. The diagnostic accuracy, sensitivity and specificity of Peguero-Lo
Presti criterion were 74.6%, 73.0% and 76.2%, respectively. The Peguero-Lo
Presti criterion had the highest sensitivity, while the Cornell criterion and
Sokolow-Lyon criterion had the highest specificity (96.8%). The area under the
curve (AUC) showed that the Peguero-Lo Presti criterion was 0.809 (95% CI,
0.730–0.874; p